QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=6F2156FD0A5778107C1127A0843C523D;jsessionid=06714C3F274B18A12D3ABD1AF87413C5;jsessionid=8AB3FE4FB551010AE44D05D72DD0A1F4;jsessionid=8020D1A24B38C0CFB101764987DC11E0;jsessionid=51B963AF2A7B01D391AE18BE56DE7457;jsessionid=BA464FB08EAEA751700CD1141987CA80;jsessionid=57266C577DDB77FA6D5BB1E8385D1BB1;jsessionid=D54988141004CEBC7B61A83FF4953BA9 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=6F2156FD0A5778107C1127A0843C523D;jsessionid=06714C3F274B18A12D3ABD1AF87413C5;jsessionid=8AB3FE4FB551010AE44D05D72DD0A1F4;jsessionid=8020D1A24B38C0CFB101764987DC11E0;jsessionid=51B963AF2A7B01D391AE18BE56DE7457;jsessionid=BA464FB08EAEA751700CD1141987CA80;jsessionid=57266C577DDB77FA6D5BB1E8385D1BB1;jsessionid=D54988141004CEBC7B61A83FF4953BA9